
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Thrombocytopenia risk factors
Introduction
Overview
Overview
High risk patients for thrombocytopenia include: Have certain types of cancer, aplastic anemia, or autoimmune diseases, are exposed to certain toxic chemicals, have a reaction to certain medicines, have certain viruses, and have certain genetic conditions.
Risk Factors
Risk Factors
People who are at highest risk for thrombocytopenia are those affected by one of the conditions or factors discussed in the “Causes” section. This includes people who:
- Have certain types of cancer, aplastic anemia, or autoimmune diseases
- Are exposed to certain toxic chemicals
- Have a reaction to certain medicines
- Have certain viruses
- Have certain genetic conditions
People at highest risk also include heavy alcohol drinkers and pregnant women.[1]
Non-alcoholic fatty liver disease, especially if with cirrhosis, may be associated with thrombocytopenia[2][3].
References
References
- ↑ [https://www.nhlbi.nih.gov/health-topics/thrombocytopenia “Thrombocytopenia | National Heart, Lung, and Blood Institute (NHLBI)”.]“Thrombocytopenia | National Heart, Lung, and Blood Institute (NHLBI)”.
- ↑ Rivera-Álvarez M, Córdova-Ramírez AC, Elías-De-La-Cruz GD, Murrieta-Álvarez I, León-Peña AA, Cantero-Fortiz Y; et al. (2021). “Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia”. Hematol Transfus Cell Ther. doi:10.1016/j.htct.2021.06.004. PMID 34312112 Check
|pmid=value (help). - ↑ Panke CL, Tovo CV, Villela-Nogueira CA, Cravo CM, Ferreira FC, Rezende GFM; et al. (2020). “Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis”. Ann Hepatol. 19 (1): 88–91. doi:10.1016/j.aohep.2019.05.011. PMID 31575467.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-In-Chief: Farbod Zahedi Tajrishi, M.D. [2]
